# Decrease of Neuropsychiatric Side Effects After Switching From Atripla to Eviplera

> **NCT02447016** · PHASE4 · TERMINATED · sponsor: **Sheba Medical Center** · enrollment: 25 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Tenofovir disoproxil/emtricitabine/rilpivirine
- **DRUG:** Tenofovir disoproxil/emtricitabine/efavirenz

## Key facts

- **NCT ID:** NCT02447016
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2016-12-21
- **Final completion:** 2016-12-21
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** no more participants taking atripla
- **Last updated:** 2017-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447016, "Decrease of Neuropsychiatric Side Effects After Switching From Atripla to Eviplera". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02447016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*